Apos Health for Knee Osteoarthritis joins the MedTech Funding Mandate

Health Innovation KSS has supported Apos Health since 2019 and it has now been announced that the company will be joining the MedTech Funding Mandate for national adoption for 2024/25.

Apos Health is a foot worn medical device that helps people with knee, hip and lower back pain relating to osteoarthritis (OA). The company registered the product with the NHS Innovation Service and received support from partners; NICE, NHS Supply Chain and Health Innovation Kent Surrey Sussex. The device is now recommended by NICE for patients with knee OA who meet the criteria for joint replacement surgery and who have not responded adequately to the recommended NICE therapies.

Apos Health now joins the MedTech Funding Mandate (MTFM) for national adoption for 2024/25. The MTFM policy was launched to support the commitments laid out in the NHS Long Term Plan to accelerate the uptake of selected innovative medical devices, diagnostics, and digital products. The MTFM aims to ensure patients and the NHS benefit from clinically effective and cost-saving medical technologies faster and more equitably.

Health Innovation KSS have supported Apos Health since 2019 and alongside their journey through HealthTech Connect and later, the NHS Innovation Service. Dr Julian O’Kelly (Innovation Manager) and Dr Charlotte Roberts (Associate Director: Innovation Adoption) have worked closely with Apos helping them to articulate their value proposition, prepare them for their NICE submission and help refine their models and value propositions. Health Innovation KSS will continue their support as Apos joins the MTFM programme 1 April 2024 and will be the lead health innovation network coordinating the spread of Apos through England through all 15 networks across the country.

Dr Roberts said: “We’re delighted to have been part of Apos’ journey over the last four years which has led to the great opportunity to now spread rapidly through the MedTech Funding Mandate programme and receive specialist spread support from all health innovation networks. Many people suffering with knee pain across the world already benefit from Apos with reduced pain and stiffness, and improved function, and we look forward to continuing to work with Apos Health and the Health Innovation Network to ensure patients and the NHS benefit from this clinically effective and cost-saving medical technology faster and more equitably.”

NHS England will be hosting The Med Tech Funding Mandate 24/25 Technology Update Webinar on 31 January, 12 – 1pm. The webinar will provide an opportunity to find out more about Apos Health and how it is transforming the management of pain and mobility challenges associated with knee OA. It will include an update on the MTFM guidance for 24/25 and an overview of MTG76 for Apos Health. This webinar will be recorded and will be available on the MTFM FuturesNHS page. Speakers will include Sachin Gohil (Apos Health Chief Commercial Officer), Dr Julian O’Kelly, Alistair Shaw (Clinician), and Sue Field (Apos recipient) sharing their experiences alongside a representative from NICE.

Sign up to the webinar now.

Learn more here:

• AposHealth for knee osteoarthritis – NICE Guidance
• Meet the innovator: Sachin Gohil of AposHealth
• Hear first-hand how Apos® patients got their lives back after many other treatments failed
• NHS Innovation Service Case Study
• Information from NHS Supply Chain on Apos health and all MTFM Technologies